Adds to Extensive Preclinical and Early Clinical Evidence that Nebokitug Interferes with Key Features of Systemic Sclerosis. TEL AVIV, Israel, (GLOBE NEWSWIRE) -- C ...

Ocugen ( OCGN -3.41%) Q4 2024 Earnings Call Mar 05, 2025, 8:30 a.m. ET ...

The attorneys general sent a letter saying the FDA needs to take action because high demand for the weight loss drugs paired ...

Tiziana Life Sciences (TLSA) announced the submission of its Investigational New Drug, IND, application to the U.S. Food and Drug ...

Scholar Rock Holding Corporation. ( NASDAQ: SRRK) Q4 2024 Earnings Conference Call February 27, 2025 8:15 AM ET Jay Backstrom - President & CEO Ted Myles - COO & CFO Tracey Sacco - Chief Commercial ...

TNG462 granted Orphan Drug Designation for treatment of pancreatic cancer –– Investigational New Drug (IND) application for TNG456, a ...

EVANSVILLE, Ind. — Two Evansville, Indiana men were sentenced to several years prison on Wednesday after they were found guilty of trafficking fentanyl. According to court documents between ...

Harmony Biosciences' (NASDAQ:HRMY) stock fell about 7.3% after U.S. FDA notified the company that it will not review the marketing application for pitolisant for the treatment of excessive daytime ...

Northstrive is working toward filing an Investigational New Drug application for EL-22 in 2025, with plans to initiate clinical trials thereafter. Deniel Mero, Co-founder of Northstrive ...

The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic CAR T-cell therapy, paving the way for a phase 1 trial in lupus and other autoimmune diseases.

TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD ... TauRx says it will file for approval of HMTM in the US and Canada next year, and before that it plans to ...